Joseph M. Casper
Equibles does not estimate personal net worth.
Get an email with a short summary when NRX Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get NRXP alertsAbout Joseph M. Casper
Joseph M. Casper is recorded as COO at NRX Pharmaceuticals, Inc. (NRXP) since January 27, 2026. NRX Pharmaceuticals, Inc. reported in an 8-K filed February 2, 2026 that Joseph M. Casper was appointed Chief Operating Officer, effective January 27, 2026. NRX Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at NRX Pharmaceuticals, Inc. includes Jonathan C. Javitt (CEO, Chairman and Board Member), Jonathan Javitt (CEO and Chairman), Stephen Willard (CEO) and 7 others.
“On January 27, 2026, the Board of Directors of the Company appointed Joseph M. Casper, age 75, as the Chief Operating Officer of the Company, effective January 27, 2026.”
Affiliation history
-
Current
2026-01-27–present
Company network
Leadership on record at NRX Pharmaceuticals, Inc.
- Jonathan C. Javitt CEO, Chairman, Board Member
- Jonathan Javitt CEO, Chairman
- Stephen Willard CEO
- Bennett Kim CFO, Board Member
- Dr. Seth Van Voorhees CFO
- Ira Strassberg CFO
- Michael Abrams CFO
- William Fricker CFO
- Joseph Casper COO
- Alessandra Daigneault General Counsel